martes, 28 de junio de 2022

FDA approves lisocabtagene maraleucel for second-line treatment of large B-cell lymphoma | FDA

FDA approves lisocabtagene maraleucel for second-line treatment of large B-cell lymphoma | FDA

No hay comentarios:

Publicar un comentario